Antifungal activity of eumelanin-inspired indoylenepheyleneethynylene against Cryptococcus neoformans

被引:0
|
作者
Conn, Brittney N. [1 ]
Lieberman, Jacob A. [1 ]
Chatman, Priscilla [1 ]
Cotton, Kaitlyn [1 ]
Essandoh, Martha A. [2 ]
Ebqa'ai, Mohammad [2 ]
Nelson, Toby L. [2 ]
Wozniak, Karen L. [1 ]
机构
[1] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA
[2] Oklahoma State Univ, Dept Chem, Stillwater, OK USA
关键词
Cryptococcus neoformans; antifungal; novel antifungal compound; EIPE-1; eumelanin; GALLERIA-MELLONELLA; CAPSULE; VIRULENCE; RESISTANCE; PATHOGEN; MODEL; EPIDEMIOLOGY; PHAGOCYTOSIS; PHARMACOLOGY; PENETRATION;
D O I
10.3389/fmicb.2023.1339303
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cryptococcus neoformans is an opportunistic fungal pathogen that causes meningitis in >152,000 immunocompromised individuals annually, leading to 112,000 yearly deaths. The four classes of existing antifungal agents target plasma membrane sterols (ergosterol), nucleic acid synthesis, and cell wall synthesis. Existing drugs are not highly effective against Cryptococcus, and antifungal drug resistance is an increasing problem. A novel antimicrobial compound, a eumelanin-inspired indoylenepheyleneethynylene, EIPE-1, was synthesized and has antimicrobial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MSRA), but not towards Gram-negative organisms. Based on EIPE-1's antibacterial activity, we hypothesized that EIPE-1 could have antifungal activity. For these studies, we tested EIPE-1 against C. neoformans strain H99 and 6 additional cryptococcal clinical isolates. We examined antifungal activity, cytotoxicity, effects on fungal gene expression, and mechanism of action of EIPE-1. Results showed that EIPE-1 has fungicidal effects on seven cryptococcal strains with MICs ranging from 1.56 to 3.125 mu g/mL depending on the strain, and it is non-toxic to mammalian cells. We conducted scanning and transmission electron microscopy on the exposed cells to examine structural changes to the organism following EIPE-1 treatment. Cells exposed displayed structural changes to their cell wall and membranes, with internal contents leaking out of the cells. To understand the effect of EIPE-1 on fungal gene expression, RNA sequencing was conducted. Results showed that EIPE-1 affects several processes involved stress response, ergosterol biosynthesis, capsule biosynthesis, and cell wall attachment and remodeling. Therefore, our studies demonstrate that EIPE-1 has antifungal activity against C. neoformans, which affects both cellular structure and gene expression of multiple fungal pathways involved in cell membrane stability and viability.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans
    Pereira, Thais C.
    do Carmo, Paulo H. F.
    de Menezes, Raquel T.
    de Oliveira, Haroldo C.
    de Oliveira, Luciane D.
    Junqueira, Juliana C.
    Scorzoni, Liliana
    FOLIA MICROBIOLOGICA, 2023, 68 (06) : 999 - 1004
  • [42] Antifungal activity from Ocimum gratissimum L. towards Cryptococcus neoformans
    Lemos, JD
    Passos, XS
    Fernandes, ODL
    de Paula, JR
    Ferri, PH
    Souza, LKHE
    Lemos, AD
    Silva, MDR
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2005, 100 (01): : 55 - 58
  • [43] Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation
    Sangalli-Leite, Fernanda
    Scorzoni, Liliana
    Alves de Paula e Silva, Ana Carolina
    da Silva, Julhiany de Fatima
    de Oliveira, Haroldo Cesar
    Singulani, Junya de Lacorte
    Gullo, Fernanda Patricia
    da Silva, Rosangela Moraes
    Regasini, Luis Octavio
    Siqueira da Silva, Dulce Helena
    Bolzani, Vanderlan da Silva
    Fusco-Almeida, Ana Marisa
    Soares Mendes-Giannini, Maria Jose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (05) : 504 - 511
  • [44] Relationship between in vitro activity of four antifungal drugs and the serotypes of Cryptococcus neoformans
    Baró, T
    Torres-Rodríguez, JM
    Alía, C
    López, O
    Morera, Y
    JOURNAL DE MYCOLOGIE MEDICALE, 2001, 11 (04): : 185 - 190
  • [45] Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays
    Trevino-Rangel, Rogelio de J.
    Villanueva-Lozano, Hiram
    Hernandez-Rodriguez, Pedro
    Martinez-Resendez, Michel F.
    Garcia-Juarez, Jaime
    Rodriguez-Rocha, Humberto
    Gonzalez, Gloria M.
    MEDICAL MYCOLOGY, 2016, 54 (03) : 280 - 286
  • [46] 3-Bromopyruvate: A novel antifungal agent against the human pathogen Cryptococcus neoformans
    Dylag, Mariusz
    Lis, Pawel
    Niedwiecka, Katarzyna
    Ko, Young H.
    Pedersen, Peter L.
    Goffeau, Andre
    Ulaszewski, Stanislaw
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (02) : 322 - 327
  • [47] Antifungal effect of lavender honey against Candida albicans, Candida krusei and Cryptococcus neoformans
    Maria Leticia Estevinho
    Sílvia Esteves Afonso
    Xesús Feás
    Journal of Food Science and Technology, 2011, 48 : 640 - 643
  • [48] Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
    Thompson, George R., III
    Wiederhold, Nathan P.
    Fothergill, Annette W.
    Vallor, Ana C.
    Wickes, Brian L.
    Patterson, Thomas F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) : 309 - 311
  • [49] Urease activity in Cryptococcus neoformans and Cryptococcus gattii
    Torres-Rodriguez, Josep M.
    Alvarado-Ramirez, Eidi
    Gutierrez-Gallego, Ricardo
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2008, 25 (01): : 27 - 31
  • [50] Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility
    Grossman, Nina T.
    Casadevall, Arturo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)